Oracle rolls out Agile PLM 9.3.1 to streamline drug development processes

Oracle claimed that Agile PLM 9.3.1 provides deeper product lifecycle analytics, next generation multi-CAD integrations, complex technical documents management, design variant management and other usability and functional enhancements.

Oracle’s Product Value Chain solution includes Agile PLM, Product Hub, AutoVue Enterprise Visualization and Product Data Quality. Relying on these offerings, customers can manage all product information, integrate product lifecycle processes and benefit from secure collaboration, data quality and knowledge management.

The existing and new Agile Enterprise PLM capabilities for pharmaceutical organizations include drug development portfolio management, comprehensive drug development records, efficient clinical supply management, faster technology transfer, integrated quality and risk management, integrated packaging and label management, and global product registration.

The latest release also includes new enhancements in Agile Product Lifecycle Analytics, Agile Next Generation CAD Connectors, Agile Design Variant Management and supports dynamic publishing of complex product documents.

Oracle PLM and PIM Product Strategy vice president Hardeep Gulati said that with this release, Oracle has added new differentiated capabilities that enable pharmaceutical drug development while also enhancing the deep cross industry capabilities delivered in Agile Enterprise PLM.

Oracle Health Sciences Global Business Unit senior vice president and general manager Neil de Crescenzo said that with the new Agile PLM capabilities and recent acquisition of Phase Forward they have a comprehensive solution for clinical trials and clinical supply management.